CTOs on the Move

MicroMRI

www.micromri.com

 
MicroMRI is a Langhorne, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.micromri.com
  • 580 Middletown Blvd
    Langhorne, PA USA 19047
  • Phone: 267.212.1100

Executives

Name Title Contact Details

Similar Companies

MDX/MEDIREX SYSTEMS

MDX/MEDIREX SYSTEMS Inc. is a Toronto, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Nurses Choice Corp

Nurses Choice Corp is a Wilmington, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Ariosa Diagnostics

Ariosa Diagnostics, Inc. is a molecular diagnostics company committed to innovating together to improve patient care. The flagship product, the Harmony™ Prenatal Test, is a safe, highly accurate and affordable prenatal test for maternal and fetal health. Led by an experienced team, Ariosa is using its proprietary technology to perform a directed analysis of cell-free DNA in blood. The Harmony™ Prenatal Test equips pregnant women and their healthcare providers with reliable information to make decisions regarding their health, without creating unnecessary stress or anxiety.

Adesis

Adesis is a New Castle, DE-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Questcor

We are a biopharmaceutical company focused on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. Our efforts are currently focused on the fields of neurology, nephrology and rheumatology, areas of medicine which have significant unmet medical needs. Our main product is H.P Acthar® Gel (repository corticotropin injection), a naturally-derived formulation of adrenocorticotropic hormones used in a variety of disorders having an inflammatory component. We are currently supporting research in a number of rare conditions, where there is significant unmet need for treatment alternatives to standard therapies. We are also actively supporting research efforts to better understand disease processes and therapeutic mechanisms of action in conditions where Acthar might potentially play a role in treatment.